ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 135077 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 135077; 2) Community: the network communities that were significantly associated with the response to NSC 135077; 3) Molecule: the relationships between components within communities and NSC 135077; 4) MDR: the compounds that were significantly associated with the NSC 135077.

NSC Compound Enrichment Correlation
NSC 720386 Methyl-12.alpha.-acetoxy-5.beta.cholan-24-oate-3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclohexane 0.0430505868034761 0.21196011
NSC 721049 7Z-Plakortide H 0.0430505868034761 0.34629428
NSC 726267 Null 0.0430505868034761 0.22525046
NSC 728038 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline 0.0430505868034761 0.28349729
NSC 730868 (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one 0.0430505868034761 0.32265786
NSC 737757 2-(4-((oxiran-2-yl)methoxy)styryl)-4,5-dihydrooxazole 0.0430505868034761 0.089538658
NSC 740 Methotrexate 0.0430505868034761 0.30304925
NSC 747461 Null 0.0430505868034761 0.042000561
NSC 751152 3-(6/7-trifluoro-3-methyl-1,4-dioxy-quinoxaline-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone 0.0430505868034761 0.29060006
NSC 758423 Amsacrine (USAN) 0.0430505868034761 0.459262
Total:126  Current:111    [First] [Prev] [Next] [Last]